|
|
|
-
Monday, August 18, 2025
4:00:49 PM
|
|
 |
|
|
All Press Releases
Team Mitsubishi Ralliart Triumphs at Asia Cross Country Rally 2025 with Chayapon Yotha's Overall Victory and Team Award
Aug 18, 2025 14:22 HKT |  | | UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
Aug 18, 2025 13:38 HKT |  | | Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
Aug 18, 2025 10:35 HKT |  | | The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
Aug 18, 2025 10:30 HKT |  | | 勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
Aug 18, 2025 10:23 HKT | | | Anime Tokyo Station Surpasses 200,000 Visitors
Aug 18, 2025 10:00 HKT |  | | 斩获12金14银11铜 摘得大满贯！首程控股多家被投企业闪耀世界人形机器人运动会
Aug 18, 2025 09:57 HKT | | | Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Aug 18, 2025 08:11 HKT |  | | RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 16, 2025 15:27 HKT |  | | WL Delicious Announced 2025 Interim Results
Aug 16, 2025 15:25 HKT |  | | MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 16, 2025 14:55 HKT |  | | Formerra Becomes North American Distributor for Syensqo PVDF
Aug 16, 2025 14:55 HKT |  | | Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 16, 2025 14:54 HKT |  | | How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT |  | | Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT |  | | Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT | | | 艾曲莫德入選《2025 ACG臨床指南：成人潰瘍性結腸炎》，獲強烈推薦用於中重度潰瘍性結腸炎的誘導緩解及維持緩解治療
Aug 15, 2025 20:07 HKT | | | 艾曲莫德入选《2025 ACG临床指南：成人溃疡性结肠炎》，获强烈推荐用于中重度溃疡性结肠炎的诱导缓解及维持缓解治疗
Aug 15, 2025 19:56 HKT | | | OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
Aug 15, 2025 19:11 HKT |  | | 業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元
Aug 15, 2025 18:53 HKT | | |
|
Next >>
|
|
|
| Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
Connect With us:
|
|